Department of Gastrointestinal and Liver Diseases, Biodonostia Health Research Institute, Spain.
Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Neurogastroenterol Motil. 2018 Sep;30(9):e13358. doi: 10.1111/nmo.13358. Epub 2018 Apr 19.
Irritable bowel syndrome (IBS) shows genetic predisposition, however, large-scale, powered gene mapping studies are lacking. We sought to exploit existing genetic (genotype) and epidemiological (questionnaire) data from a series of population-based cohorts for IBS genome-wide association studies (GWAS) and their meta-analysis.
Based on questionnaire data compatible with Rome III Criteria, we identified a total of 1335 IBS cases and 9768 asymptomatic individuals from 5 independent European genotyped cohorts. Individual GWAS were carried out with sex-adjusted logistic regression under an additive model, followed by meta-analysis using the inverse variance method. Functional annotation of significant results was obtained via a computational pipeline exploiting ontology and interaction networks, and tissue-specific and gene set enrichment analyses.
Suggestive GWAS signals (P ≤ 5.0 × 10 ) were detected for 7 genomic regions, harboring 64 gene candidates to affect IBS risk via functional or expression changes. Functional annotation of this gene set convincingly (best FDR-corrected P = 3.1 × 10 ) highlighted regulation of ion channel activity as the most plausible pathway affecting IBS risk.
CONCLUSION & INFERENCES: Our results confirm the feasibility of population-based studies for gene-discovery efforts in IBS, identify risk genes and loci to be prioritized in independent follow-ups, and pinpoint ion channels as important players and potential therapeutic targets warranting further investigation.
肠易激综合征(IBS)显示出遗传倾向,但缺乏大规模、有力的基因图谱研究。我们试图利用一系列基于人群的队列中现有的遗传(基因型)和流行病学(问卷)数据进行 IBS 的全基因组关联研究(GWAS)及其荟萃分析。
基于符合罗马 III 标准的问卷数据,我们从 5 个独立的欧洲基因分型队列中总共确定了 1335 例 IBS 病例和 9768 例无症状个体。采用加性模型进行性别调整后的逻辑回归进行个体 GWAS,然后使用逆方差法进行荟萃分析。通过利用本体论和交互网络的计算管道对显著结果进行功能注释,并进行组织特异性和基因集富集分析。
检测到 7 个基因组区域存在提示性 GWAS 信号(P≤5.0×10),这些区域包含 64 个候选基因,通过功能或表达变化影响 IBS 风险。该基因集的功能注释令人信服(最佳 FDR 校正 P=3.1×10),突出了离子通道活性的调节是影响 IBS 风险的最合理途径。
我们的结果证实了基于人群的研究在 IBS 基因发现工作中的可行性,确定了风险基因和位点,以便在独立的后续研究中进行优先排序,并指出离子通道是重要的参与者和潜在的治疗靶点,值得进一步研究。